Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. - Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; et al. (BMJ (Clinical research ed.), 2018)